• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Ambuja Cements Ltd
Industry :  Cement - North India
BSE Code
ISIN Demat
Book Value()
500425
INE079A01024
211.5270843
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AMBUJACEM
27.95
108425
EPS(TTM)
Face Value()
Div & Yield %
15.61
2
0.46
 

Shree Ganesh Biotech India reports standalone net loss of Rs 0.15 crore in the March 2026 quarter
May 15,2026
Net Loss of Shree Ganesh Biotech India reported to Rs 0.15 crore in the quarter ended March 2026 as against net loss of Rs 0.95 crore during the previous quarter ended March 2025. Sales declined 29.57% to Rs 2.12 crore in the quarter ended March 2026 as against Rs 3.01 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.71% to Rs 0.38 crore in the year ended March 2026 as against Rs 0.28 crore during the previous year ended March 2025. Sales declined 78.35% to Rs 4.97 crore in the year ended March 2026 as against Rs 22.96 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.123.01 -30 4.9722.96 -78
OPM %-20.28-47.18 --19.11-4.57 -
PBDT-0.15-0.95 84 0.520.39 33
PBT-0.15-0.95 84 0.520.39 33
NP-0.15-0.95 84 0.380.28 36